Skip to main content

FTC sues to block Amgen’s acquisition of Horizon Therapeutics

Deal could allow Amgen to "entrench the monopoly positions" of two Horizon medications, regulators say.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.